Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Theunissen, T. W., Powell, B. E., Wang, H., Mitalipova, M., Faddah, D. A., Reddy, J., Fan, Z. P., Maetzel, D., Ganz, K., Shi, L., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.07.002 · Cited by 888
A decade of transcription factor-mediated reprogramming to pluripotency
Takahashi, K., & Yamanaka, S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.8 · Cited by 878
Guo, Z., Zhang, L., Wu, Z., Chen, Y., Wang, F., & Chen, G. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.12.001 · Cited by 832
Schiebinger, G., Shu, J., Tabaka, M., Cleary, B., Subramanian, V., Solomon, A., Gould, J., Liu, S., Lin, S., Berube, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.006 · Cited by 829
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Hu, W., Qiu, B., Guan, W., Wang, Q., Wang, M., Li, W., Gao, L., Shen, L., Huang, Y., Xie, G., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.006 · Cited by 484
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons.
Li, X., Zuo, X., Jing, J., Ma, Y., Wang, J., Liu, D., Zhu, J., Du, X., Xiong, L., Du, Y., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.003 · Cited by 428
Self-citationDirect Lineage Reprogramming: Strategies, Mechanisms, and Applications
Xu, J., Du, Y., & Deng, H. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.01.013 · Cited by 426
Self-citationReactive Oxygen Species in Normal and Tumor Stem Cells
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-420117-0.00001-3 · Cited by 403
Chromatin dynamics during cellular reprogramming
Apostolou, E., & Hochedlinger, K. (2013) · Nature · doi:10.1038/nature12749 · Cited by 398
De Los Angeles, A., Ferrari, F., Xi, R., Fujiwara, Y., Benvenisty, N., Deng, H., Hochedlinger, K., Jaenisch, R., Lee, S., Leitch, H. G., et al. (2015) · Nature · doi:10.1038/nature15515 · Cited by 396
Self-citationHu, G.-W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S.-M., Guo, S.-C., Lang, H.-L., Zhang, C.-Q., Wang, Y., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/scrt546 · Cited by 391
Chemical reprogramming of human somatic cells to pluripotent stem cells.
Guan, J., Wang, G., Wang, J., Zhang, Z., Fu, Y., Cheng, L., Meng, G., Lyu, Y., Zhu, J., Li, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04593-5 · Cited by 388
Self-citationInduced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
WNT Signaling in Cardiac and Vascular Disease
Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., & Blankesteijn, W. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.013896 · Cited by 347
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons
Zhang, L., Yin, J.-C., Yeh, H., Ma, N.-X., Lee, G., Chen, X. A., Wang, Y., Lin, L., Chen, L., Jin, P., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.012 · Cited by 289
Moradi, S., Mahdizadeh, H., Šarić, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1455-y · Cited by 287
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
Wang, S., Du, Y., Zhang, B., Meng, G., Liu, Z., Liew, S. Y., Liang, R., Zhang, Z., Cai, X., Wu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.004 · Cited by 281
Self-citationTranslation of Human-Induced Pluripotent Stem Cells
Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 279
Self-citationRethinking Differentiation: Stem Cells, Regeneration, and Plasticity
Sánchez Alvarado, A., & Yamanaka, S. (2014) · Cell · doi:10.1016/j.cell.2014.02.041 · Cited by 276
Nebert, D. W. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.06.001 · Cited by 275
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications
Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 264
A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming
Zhao, Y., Zhao, T., Guan, J., Zhang, X., Fu, Y., Ye, J., Zhu, J., Meng, G., Ge, J., Yang, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.017 · Cited by 263
Self-citationKatsuda, T., Kawamata, M., Hagiwara, K., Takahashi, R.-U., Yamamoto, Y., Camargo, F. D., & Ochiya, T. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.10.007 · Cited by 260
RETRACTED ARTICLE: Stimulus-triggered fate conversion of somatic cells into pluripotency
Obokata, H., Wakayama, T., Sasai, Y., Kojima, K., Vacanti, M. P., Niwa, H., Yamato, M., & Vacanti, C. A. (2014) · Nature · doi:10.1038/nature12968 · Cited by 260
RetractedGeneration of neural progenitor cells by chemical cocktails and hypoxia
Cheng, L., Hu, W., Qiu, B., Zhao, J., Yu, Y., Guan, W., Wang, M., Yang, W., & Pei, G. (2014) · Cell Research · doi:10.1038/cr.2014.32 · Cited by 254
Self-citationTargeting the pancreatic β-cell to treat diabetes
Vetere, A., Choudhary, A., Burns, S. M., & Wagner, B. K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4231 · Cited by 252
Functional hair follicle regeneration: an updated review
Ji, S., Zhu, Z., Sun, X., & Fu, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00441-y · Cited by 249
Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.
Fu, Y., Huang, C., Xu, X., Gu, H., Ye, Y., Jiang, C., Qiu, Z., & Xie, X. (2015) · Cell Research · doi:10.1038/cr.2015.99 · Cited by 248
3D Spatiotemporal Mechanical Microenvironment: A Hydrogel‐Based Platform for Guiding Stem Cell Fate
Ma, Y., Lin, M., Huang, G., Li, Y., Wang, S., Bai, G., Lu, T. J., & Xu, F. (2018) · Advanced Materials · doi:10.1002/adma.201705911 · Cited by 228
Self-citationPluripotent stem cell energy metabolism: an update
Teslaa, T., & Teitell, M. A. (2015) · The EMBO Journal · doi:10.15252/embj.201490446 · Cited by 217
Pluripotent Stem Cells: Current Understanding and Future Directions
Romito, A., & Cobellis, G. (2016) · Stem Cells International · doi:10.1155/2016/9451492 · Cited by 215
Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
Müller, P., Lemcke, H., & David, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492704 · Cited by 215
Stemming retinal regeneration with pluripotent stem cells
Jin, Z.-B., Gao, M.-L., Deng, W.-L., Wu, K.-C., Sugita, S., Mandai, M., & Takahashi, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.003 · Cited by 213
Jiang, Y., Cai, Y., Zhang, W., Yin, Z., Hu, C., Tong, T., Lu, P., Zhang, S., Neculai, D., Tuan, R. S., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0192 · Cited by 209
C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells
Di Stefano, B., Sardina, J. L., van Oevelen, C., Collombet, S., Kallin, E. M., Vicent, G. P., Lu, J., Thieffry, D., Beato, M., & Graf, T. (2014) · Nature · doi:10.1038/nature12885 · Cited by 200
He, J., Babarinde, I. A., Sun, L., Xu, S., Chen, R., Shi, J., Wei, Y., Li, Y., Ma, G., Zhuang, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21808-x · Cited by 200
Self-citationVieira, M. S., Santos, A. K., Vasconcellos, R., Goulart, V. A. M., Parreira, R. C., Kihara, A. H., Ulrich, H., & Resende, R. R. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.002 · Cited by 191
Chemical Approaches to Stem Cell Biology and Therapeutics
Li, W., Li, K., Wei, W., & Ding, S. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.08.002 · Cited by 183
Zunder, E. R., Lujan, E., Goltsev, Y., Wernig, M., & Nolan, G. P. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.01.015 · Cited by 181
Valamehr, B., Robinson, M., Abujarour, R., Rezner, B., Vranceanu, F., Le, T., Medcalf, A., Lee, T. T., Fitch, M., Robbins, D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.014 · Cited by 180
Lyu, G., Guan, Y., Zhang, C., Zong, L., Sun, L., Huang, X., Huang, L., Zhang, L., Tian, X.-L., Zhou, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04994-z · Cited by 176
Reprogramming of cell fate: epigenetic memory and the erasure of memories past
Nashun, B., Hill, P. W., & Hajkova, P. (2015) · The EMBO Journal · doi:10.15252/embj.201490649 · Cited by 175
Concise Review: Bioprinting of Stem Cells for Transplantable Tissue Fabrication
Leberfinger, A. N., Ravnic, D. J., Dhawan, A., & Ozbolat, I. T. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0148 · Cited by 175
Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target
Kolluri, S. K., Jin, U.-H., & Safe, S. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1981-2 · Cited by 173
In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells
Li, H., & Chen, G. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.004 · Cited by 172
Self-citationInduced Pluripotent Stem Cells for Regenerative Medicine
Hirschi, K. K., Li, S., & Roy, K. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105108 · Cited by 148
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Kim, Y., Kang, K., Lee, S. B., Seo, D., Yoon, S., Kim, S. J., Jang, K., Jung, Y. K., Lee, K. G., Factor, V. M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.007 · Cited by 167
High-efficiency RNA-based reprogramming of human primary fibroblasts
Kogut, I., McCarthy, S. M., Pavlova, M., Astling, D. P., Chen, X., Jakimenko, A., Jones, K. L., Getahun, A., Cambier, J. C., Pasmooij, A. M. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03190-3 · Cited by 166
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives
Zomer, H. D., Vidane, A. S., Gonçalves, N. N., & Ambrósio, C. E. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s88036 · Cited by 166
Cellular Metabolism and Induced Pluripotency
Wu, J., Ocampo, A., & Belmonte, J. C. I. (2016) · Cell · doi:10.1016/j.cell.2016.08.008 · Cited by 162
Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line
Sluch, V. M., Davis, C.-H. O., Ranganathan, V., Kerr, J. M., Krick, K., Martin, R., Berlinicke, C. A., Marsh-Armstrong, N., Diamond, J. S., Mao, H.-Q., et al. (2015) · Scientific Reports · doi:10.1038/srep16595 · Cited by 154
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases
Ji, S., Xiong, M., Chen, H., Liu, Y., Zhou, L., Hong, Y., Wang, M., Wang, C., Fu, X., & Sun, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01343-5 · Cited by 159
Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs during Chemical Reprogramming
Zhao, T., Fu, Y., Zhu, J., Liu, Y., Zhang, Q., Yi, Z., Chen, S., Jiao, Z., Xu, X., Xu, J., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.025 · Cited by 159
Self-citationOCT4: Dynamic DNA binding pioneers stem cell pluripotency
Jerabek, S., Merino, F., Schöler, H. R., & Cojocaru, V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.10.001 · Cited by 158
Tissue Engineering and Regenerative Medicine: A Year in Review
Harrison, R. H., St‐Pierre, J., & Stevens, M. M. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0668 · Cited by 159
Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates
Du, Y., Liang, Z., Wang, S., Sun, D., Wang, X., Liew, S. Y., Lu, S., Wu, S., Jiang, Y., Wang, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01645-7 · Cited by 155
Self-citationd’Angelo, M., Benedetti, E., Tupone, M. G., Catanesi, M., Castelli, V., Antonosante, A., & Cimini, A. (2019) · Cells · doi:10.3390/cells8091036 · Cited by 153
Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
Heslop, J. A., Hammond, T. G., Santeramo, I., Tort Piella, A., Hopp, I., Zhou, J., Baty, R., Graziano, E. I., Proto Marco, B., Caron, A., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0110 · Cited by 139
Molecular Control of Induced Pluripotency
Theunissen, T. W., & Jaenisch, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.05.002 · Cited by 134
FutureTox II: In vitro Data and In Silico Models for Predictive Toxicology
Knudsen, T. B., Keller, D. A., Sander, M., Carney, E. W., Doerrer, N. G., Eaton, D. L., Fitzpatrick, S. C., Hastings, K. L., Mendrick, D. L., Tice, R. R., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu234 · Cited by 132
Direct Cardiac Reprogramming: Progress and Challenges in Basic Biology and Clinical Applications
Sadahiro, T., Yamanaka, S., & Ieda, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.305374 · Cited by 132
Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs
Velychko, S., Adachi, K., Kim, K.-P., Hou, Y., MacCarthy, C. M., Wu, G., & Schöler, H. R. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.10.002 · Cited by 131
Hojo, H., Ohba, S., He, X., Lai, L. P., & McMahon, A. P. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.04.002 · Cited by 143
The Information Theory of Aging
Lu, Y. R., Tian, X., & Sinclair, D. A. (2023) · Nature Aging · doi:10.1038/s43587-023-00527-6 · Cited by 141
Sabapathy, V., & Kumar, S. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12839 · Cited by 123
Cellular reprogramming and epigenetic rejuvenation
Simpson, D. J., Olova, N. N., & Chandra, T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01158-7 · Cited by 126
Theunissen, T. W., Powell, B. E., Wang, H., Mitalipova, M., Faddah, D. A., Reddy, J., Fan, Z. P., Maetzel, D., Ganz, K., Shi, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.09.003 · Cited by 139
TGF-β signaling in cell fate control and cancer
Yu, Y., & Feng, X. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.007 · Cited by 138
Kang, R., Zhou, Y., Tan, S., Zhou, G., Aagaard, L., Xie, L., Bünger, C. E., Bolund, L., & Luo, Y. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0137-7 · Cited by 137
Chemically induced reprogramming to reverse cellular aging
Yang, J.-H., Petty, C. A., Dixon-McDougall, T., Lopez, M. V., Tyshkovskiy, A., Maybury-Lewis, S., Tian, X., Ibrahim, N., Chen, Z., Griffin, P. T., et al. (2023) · Aging · doi:10.18632/aging.204896 · Cited by 136
Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming.
Liuyang, S., Wang, G., Wang, Y., He, H., Lyu, Y., Cheng, L., Yang, Z., Guan, J., Fu, Y., Zhu, J., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.02.008 · Cited by 136
Self-citationCurrent perspectives in stem cell research for knee cartilage repair
Orth, P., Rey‐Rico, A., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2014) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s42880 · Cited by 135
Nicolas, C. T., Hickey, R. D., Chen, H. S., Mao, S. A., Lopera Higuita, M., Wang, Y., & Nyberg, S. L. (2017) · Stem Cells · doi:10.1002/stem.2500 · Cited by 127
SALL4, the missing link between stem cells, development and cancer
Tatetsu, H., Kong, N. R., Chong, G., Amabile, G., Tenen, D. G., & Chai, L. (2016) · Gene · doi:10.1016/j.gene.2016.02.019 · Cited by 130
Jiang, B., Yan, L., Wang, X., Li, E., Murphy, K. A., Vaccaro, K., Li, Y., & Xu, R. (2018) · Stem Cells · doi:10.1002/stem.2964 · Cited by 130
Self-citationTian, Z., Yu, T., Liu, J., Wang, T., & Higuchi, A. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.02.012 · Cited by 131
On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology
Shao, Y., Sang, J., & Fu, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.078 · Cited by 110
Induced Pluripotency and Epigenetic Reprogramming
Hochedlinger, K., & Jaenisch, R. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019448 · Cited by 111
Cieślar‐Pobuda, A., Knoflach, V., Ringh, M. V., Stark, J., Likus, W., Siemianowicz, K., Ghavami, S., Hudecki, A., Green, J. L., & Łoś, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.017 · Cited by 128
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
A developmental framework for induced pluripotency
Takahashi, K., & Yamanaka, S. (2015) · Development · doi:10.1242/dev.114249 · Cited by 111
Cultivated meat manufacturing: Technology, trends, and challenges
Kirsch, M., Morales-Dalmau, J., & Lavrentieva, A. V. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202300227 · Cited by 127
Lin28 Signaling Supports Mammalian PNS and CNS Axon Regeneration
Wang, X., Li, Q., Liu, C.-M., Hall, P. A., Jiang, J.-J., Katchis, C. D., Kang, S., Dong, B. C., Li, S., & Zhou, F. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.105 · Cited by 125
Self-citationResolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq
Guo, L., Lin, L., Wang, X., Gao, M., Cao, S., Mai, Y., Wu, F., Kuang, J., Liu, H., Yang, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.042 · Cited by 113
Small-molecule-mediated reprogramming: a silver lining for regenerative medicine
Kim, Y., Jeong, J., & Choi, D. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0383-3 · Cited by 101
Small molecules facilitate rapid and synchronous iPSC generation
Bar-Nur, O., Brumbaugh, J., Verheul, C., Apostolou, E., Pruteanu-Malinici, I., Walsh, R. M., Ramaswamy, S., & Hochedlinger, K. (2014) · Nature Methods · doi:10.1038/nmeth.3142 · Cited by 107
Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo
Dal-Pra, S., Hodgkinson, C. P., Mirotsou, M., Kirste, I., & Dzau, V. J. (2017) · Circulation Research · doi:10.1161/circresaha.116.308741 · Cited by 119
Small molecules for reprogramming and transdifferentiation
Qin, H., Zhao, A., & Fu, X. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2586-x · Cited by 119
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells
Xue, Y., Qian, H., Hu, J., Zhou, B., Zhou, Y., Hu, X., Karakhanyan, A., Pang, Z., & Fu, X.-D. (2016) · Nature Neuroscience · doi:10.1038/nn.4297 · Cited by 118
3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
Suarez-Martinez, E., Suazo-Sanchez, I., Celis-Romero, M., & Carnero, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00775-w · Cited by 118
The potential of induced pluripotent stem cell derived hepatocytes
Hannoun, Z., Steichen, C., Dianat, N., Weber, A., & Dubart‐Kupperschmitt, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.025 · Cited by 113
Kang, J. X., Wan, J., & He, C. (2013) · Stem Cells · doi:10.1002/stem.1620 · Cited by 113
Early reprogramming regulators identified by prospective isolation and mass cytometry
Lujan, E., Zunder, E. R., Ng, Y. H., Goronzy, I. N., Nolan, G. P., & Wernig, M. (2015) · Nature · doi:10.1038/nature14274 · Cited by 103
Integration-Free Methods for Generating Induced Pluripotent Stem Cells
Zhou, Y., & Zeng, F. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.008 · Cited by 111
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.